Cargando…

Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells

Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that triggers adaptive responses upon low oxygen conditions and plays a crucial role in cancer metabolism and therapy resistance. Tetrathiomolybdate (TM), a therapy option for copper overload disorder, has also been shown to be capable o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwang Kim, Kyu, Abelman, Sarah, Yano, Naohiro, Ribeiro, Jennifer R., Singh, Rakesh K., Tipping, Marla, Moore, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606568/ https://www.ncbi.nlm.nih.gov/pubmed/26469226 http://dx.doi.org/10.1038/srep14296

Ejemplares similares

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
por: Kim, Kyu Kwang, et al.
Publicado: (2015)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Tetrathiomolybdate Decreases the Expression of Alkaline Phosphatase in Dermal Papilla Cells by Increasing Mitochondrial ROS Production
por: Li, Fan, et al.
Publicado: (2023)

Ammonium tetrathiomolybdate treatment of copper‐associated hepatopathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2019)

Hypoxia Promotes Mitochondrial Complex I Abundance via HIF-1α in Complex III and Complex IV Deficient Cells
por: Saldana-Caboverde, Amy, et al.
Publicado: (2020)

Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
por: Fang, Tiantian, et al.
Publicado: (2019)

Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate
por: Navrátilová, Jarmila, et al.
Publicado: (2017)

Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
por: Li, Xiang, et al.
Publicado: (2020)

Bis-choline tetrathiomolybdate prevents copper-induced blood–brain barrier damage
por: Borchard, Sabine, et al.
Publicado: (2021)

Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats
por: Omoto, Atsushi, et al.
Publicado: (2005)

Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells
por: Zhang, Mengling, et al.
Publicado: (2022)

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series
por: De Fabregues, Oriol, et al.
Publicado: (2020)

The copper chelator ammonium tetrathiomolybdate inhibits the progression of experimental endometriosis in TNFR1-deficient mice
por: Conforti, Rocío Ayelem, et al.
Publicado: (2023)

Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
por: Liu, Ying L., et al.
Publicado: (2021)

Bis‐choline Tetrathiomolybdate as Old Drug in a New Design for Wilson’s Disease: Good for Brain and Liver?
por: Stremmel, Wolfgang
Publicado: (2018)

Tetrathiomolybdate Treatment Attenuates Bleomycin-Induced Angiogenesis and Lung Pathology in a Sheep Model of Pulmonary Fibrosis
por: Derseh, Habtamu B., et al.
Publicado: (2021)

Analyzing the Therapeutic Efficacy of Bis-Choline-Tetrathiomolybdate in the Atp7b(−/−) Copper Overload Mouse Model
por: Kim, Philipp, et al.
Publicado: (2021)

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
por: Doñate, F, et al.
Publicado: (2008)

Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
por: Chisholm, Cristine L., et al.
Publicado: (2016)

Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
por: Mendonça, Bruna Pescador, et al.
Publicado: (2020)

Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models
por: Dyson, Alex, et al.
Publicado: (2017)

Xanthine Oxidase Mediates Hypoxia-Inducible Factor-2α Degradation by Intermittent Hypoxia
por: Nanduri, Jayasri, et al.
Publicado: (2013)

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
por: Kumar, Pawan, et al.
Publicado: (2010)

Evaluation of ATOX1 as a Potential Predictive Biomarker for Tetrathiomolybdate Treatment of Breast Cancer Patients with High Risk of Recurrence
por: Blockhuys, Stéphanie, et al.
Publicado: (2021)

Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway
por: Qi, Hao, et al.
Publicado: (2023)

Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H(2)O(2) generation: antagonism by tetrathiomolybdate
por: Calderon-Aparicio, Ali, et al.
Publicado: (2015)

Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma
por: Ryumon, Shoji, et al.
Publicado: (2019)

Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells
por: Boulet, Marie H. C., et al.
Publicado: (2023)

Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate
por: Joimel, Ulrich, et al.
Publicado: (2010)

Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia
por: Wang, Zhuo, et al.
Publicado: (2018)

The Complexity of Mitochondrial Complex IV: An Update of Cytochrome c Oxidase Biogenesis in Plants
por: Mansilla, Natanael, et al.
Publicado: (2018)

Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation†
por: Schreiber-Brynzak, Ekaterina, et al.
Publicado: (2016)

Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation
por: Yin, Yinghao, et al.
Publicado: (2021)

Paraxial Ocular Measurements and Entries in Spectral and Modal Matrices: Analogy and Application
por: Abelman, Herven, et al.
Publicado: (2014)

Tolerance and Nature of Residual Refraction in Symmetric Power Space as Principal Lens Powers and Meridians Change
por: Abelman, Herven, et al.
Publicado: (2014)

A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
por: Dahia, Patricia L. M, et al.
Publicado: (2005)

Mitochondrial complex I ROS production and redox signaling in hypoxia
por: Okoye, Chidozie N., et al.
Publicado: (2023)

Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status
por: Calderon-Aparicio, Ali, et al.
Publicado: (2019)

Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia
por: Chowdhury, Arpita, et al.
Publicado: (2018)

Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6
por: James, Nicole E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sl1pilirovgmo277vva6nk510e